Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
McGee, Amanda
Spectra, NCT05393284: Phase 2 Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy	Active, not recruiting	2	114	US	OPL-0401 Dose 1, Placebo	Valo Health, Inc.	Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy	08/24	08/24
O'Daniell, Gabrielle
Spectra, NCT05393284: Phase 2 Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy	Active, not recruiting	2	114	US	OPL-0401 Dose 1, Placebo	Valo Health, Inc.	Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy	08/24	08/24